This measure was introduced in September 2025. It reauthorizes the C.W. Bill Young Cell Transplantation Program by changing funding language and extends a cord blood inventory deadline. The text replaces a single appropriation line with two paragraphs: one that lists $31,009,000 and a second that authorizes $33,009,000 for each of fiscal years 2027 through 2031. It also amends a provision of the 2005 stem cell statute to change a cited year from 2026 to 2031.
If you are a donor, patient, clinician, or program involved with cord blood or marrow transplantation, this measure keeps an existing appropriation figure and adds a repeated annual funding amount for 2027–2031. It also moves the deadline or target year for the cord blood inventory provision from 2026 to 2031.
The text specifies two appropriation lines: (1) $31,009,000, and (2) $33,009,000 for each of fiscal years 2027 through 2031. No publicly available information on other costs or budget offsets is included in the provided text.
No publicly available information.
No publicly available information.